DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b553ab/oral_contraceptive) has announced the addition of Future Science Ltd's new report "Oral contraceptive pills: Advances and progress over the last 50 years" to their offering.
It has been 50 years since the first oral contraceptive pills were approved for public use in Great Britain, and to mark this milestone, this special issue focuses on the advances and progress that have been made in this field of research. A number of experts in the field discuss the current situation in hormonal contraception, including an overview of currently available pills, our present knowledge of risks and side effects, as well as of the benefits - both contraceptive and non contraceptive - that oral contraceptive pills can offer. On the social front, women's expectations when opting for hormonal contraception - and how these changed over time - is summarized; in addition, patterns of use and the somewhat controversial topic of over-the-counter distribution is also debated.
Key Topics Covered:
FOREWORD
- Oral contraceptive pills: advances and progress over the last 50 years
EDITORIAL
- Combined oral contraceptive pill and venous thromboembolism
- Obesity and the combined oral contraceptive pill: efficacy and effects
NEWS IN BRIEF
KEY PAPER EVALUATION
- Use of combined oral contraceptives for the management of heavy menstrual bleeding
- Do I practice what I preach? Contraception use in North American medical students
SPECIAL REPORT
- Role of combined oral contraceptives in women undergoing assisted reproduction treatment
PERSPECTIVE
- Over-the-counter access to oral contraceptives
- What women want from their oral contraceptives
REVIEW
- Currently available combined oral contraception
- Oral contraception: from birth control to pregnancy prevention with noncontraceptive benefits
- Health issues in oral contraception: risks, side effects and health benefits
- Contraception and preconception counseling in special populations
- Emergency contraception: presently available formulations and controversies surrounding their use
ACKNOWLEDGEMENTS
For more information visit http://www.researchandmarkets.com/research/b553ab/oral_contraceptive